Bolt Biotherapeutics, Inc.

NASDAQ:BOLT

0.6513 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12001 Q3
Operating Activities:
Net Income -21.195-10.811-17.903-16.257-18.057-16.98-19.997-21.759-22.664-23.678-27.157-23.395-23.585-24.454-31.035-10.001-11.059-8.633-9.362-7.184-6.971-6.9710
Depreciation & Amortization 0.4570.4580.4970.4620.4580.4670.4620.4390.4080.3570.3610.3040.2560.2720.2210.1790.110.1010.096-0.1370.1880.1880
Deferred Income Tax 00-3.062-1.335-1.112000000.9290.8220.740.2710.0550.031-0.019-0.03300000
Stock Based Compensation 2.8252.3022.0682.3292.352.4762.1232.1432.3912.9192.1422.2262.0232.1090.5690.4030.2230.2250.2730.0870.0740.0740
Change In Working Capital 1.774-8.441.539-2.6920.518-9.229-0.7745.082-1.816-5.5495.3870.55515.936-1.3712.634-1.214-1.979-1.7242.319-0.746-0.506-0.5060
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables 0-3.5443.19800-6.6118.2470-3.087-2.3926.67600-0.0882.88200000000
Other Working Capital 1.774-8.441.539-2.6920.518-2.618-9.021-1.2091.271-3.157-1.2890.55515.936-1.283-0.248-1.214-1.979-1.7242.319-0.746-0.506-0.5060
Other Non Cash Items 3.7362.9582.5960.7440.731-0.1330.2340.6820.8941.6370.5440.7610.6446.61414.666-1.9130.4590.4260.412-0.3021.3151.3150
Operating Cash Flow -16.142-16.751-14.265-16.749-15.112-23.399-17.952-13.451-20.787-24.314-17.794-18.727-3.986-16.559-12.89-12.515-12.265-9.638-6.262-8.282-5.9-5.90
Investing Activities:
Investments In Property Plant And Equipment 00-0.006-0.165-0.032-0.003-0.184-0.735-0.429-0.605-0.562-1.015-0.703-0.058-0.898-1.151-0.84-0.373-0.067-0.239-0.101-0.1010
Acquisitions Net 0055.429-12.823-13.612-28.994-16.61900.43900000000000000
Purchases Of Investments -32.225-23.058-32.16-36.304-53.641-42.883-25.359-47.912-31.349-76.084-29.687-35.92-49.699-198.0690-19.9940-13.23500000
Sales Maturities Of Investments 50.22833.26147.97549.12767.25371.87741.97850.09730.91117.53451.28220.8243.87.6062.6028.055.247000000
Other Investing Activites 18.00310.203-012.82313.61228.99416.6192.185-0.43941.4521.595-15.096-45.899-190.4632.602-11.9445.247-13.23500000
Investing Cash Flow 18.00310.20315.80912.65813.5828.99116.4351.45-0.86840.84521.033-16.111-46.602-190.5211.704-13.0954.407-13.608-0.067-0.239-0.101-0.1010
Financing Activities:
Debt Repayment 0000000000000000000-0.021000
Common Stock Issued 0.07900.10600.14700.14400.2520.1070.4950.18513.409297.0190.0780.1770.0050.0340.0260000
Common Stock Repurchased 0.0790-0.141000000013.638000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities 0.07900.10600.14700.14400.2520.1070.4950.18513.409297.019-1.143-1.141.5460.0340.02622.39713.11313.1130
Financing Cash Flow 0.07900.10600.14700.14400.2520.1070.4950.18513.409297.019-1.065-0.92341.5510.0340.02622.37613.11313.1130
Other Information:
Effect Of Forex Changes On Cash 0014.3580-14.358000000000000000000
Net Change In Cash 1.94-6.5481.65-4.091-1.3855.592-1.373-12.001-21.40316.6383.734-34.653-37.17989.939-12.251-26.53333.693-23.212-6.30313.8557.1127.1120
Cash At End Of Period 6.2024.26210.8110.92515.01616.40110.80912.18224.18345.58628.94825.21459.86797.0467.10719.35845.89112.19835.4141.71327.8587.1120